Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 21% ± 5% | |
endothelial cell | 4 studies | 19% ± 3% | |
oligodendrocyte | 4 studies | 23% ± 4% | |
goblet cell | 3 studies | 28% ± 10% | |
glutamatergic neuron | 3 studies | 39% ± 14% | |
GABAergic neuron | 3 studies | 36% ± 12% | |
astrocyte | 3 studies | 34% ± 8% | |
oligodendrocyte precursor cell | 3 studies | 28% ± 9% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 36% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1074.79 | 1445 / 1445 | 100% | 5.35 | 183 / 183 |
prostate | 100% | 1377.05 | 245 / 245 | 100% | 7.98 | 502 / 502 |
brain | 100% | 1074.22 | 2638 / 2642 | 100% | 6.90 | 705 / 705 |
lung | 100% | 1233.48 | 578 / 578 | 100% | 5.23 | 1152 / 1155 |
thymus | 100% | 1383.56 | 653 / 653 | 100% | 6.58 | 603 / 605 |
stomach | 100% | 882.56 | 359 / 359 | 100% | 5.70 | 285 / 286 |
breast | 100% | 1417.64 | 459 / 459 | 100% | 7.21 | 1113 / 1118 |
kidney | 100% | 955.87 | 89 / 89 | 99% | 6.39 | 894 / 901 |
bladder | 100% | 1310.52 | 21 / 21 | 99% | 5.11 | 499 / 504 |
uterus | 100% | 1715.00 | 170 / 170 | 98% | 4.35 | 452 / 459 |
pancreas | 99% | 639.18 | 326 / 328 | 99% | 5.68 | 176 / 178 |
intestine | 100% | 1456.03 | 966 / 966 | 98% | 5.29 | 517 / 527 |
ovary | 100% | 1476.01 | 180 / 180 | 98% | 3.05 | 421 / 430 |
adrenal gland | 100% | 661.11 | 257 / 258 | 98% | 3.91 | 225 / 230 |
skin | 100% | 1111.56 | 1809 / 1809 | 92% | 3.99 | 432 / 472 |
liver | 95% | 384.96 | 214 / 226 | 86% | 2.53 | 351 / 406 |
adipose | 100% | 1296.49 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1327.21 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 1400.04 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 3.31 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.21 | 1 / 1 |
muscle | 100% | 737.65 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 625.59 | 845 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 3.06 | 28 / 29 |
peripheral blood | 87% | 570.93 | 807 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 74% | 2.30 | 59 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0016592 | Cellular component | mediator complex |
GO_0005739 | Cellular component | mitochondrion |
GO_0003677 | Molecular function | DNA binding |
GO_0003712 | Molecular function | transcription coregulator activity |
Gene name | BCLAF3 |
Protein name | BCLAF1 and THRAP3 family member 3 CXorf23 protein |
Synonyms | CXorf23 |
Description | |
Accessions | H7BXX2 ENST00000472158.5 F2Z385 A2AJT9 ENST00000379687.8 [A2AJT9-2] ENST00000340625.3 B7ZLM9 ENST00000379682.9 [A2AJT9-1] |